Sleep and Cerebral Responses to High Altitude (VALLOT 2011)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by University Hospital, Grenoble.
Recruitment status was Active, not recruiting
Information provided by (Responsible Party):
AdministrateurDRC, University Hospital, Grenoble
First received: March 26, 2012
Last updated: March 29, 2012
Last verified: March 2012
Mechanisms underlying high-altitude intolerance as well as exercise performance limitation in hypoxia still remain to be fully understood. Recent data suggest that sleep disturbances on one hand and cerebral perturbations on teh other hand may be key mechanisms. The investigators evaluated 12 healthy subjects at sea level and at 4400 m of altitude for 7 days in order to better describe sleep and cerebral responses. The investigators hypothesized that sleep and cerebral disturbances play a critical role for the developement of acute mountain sickness and for exercise performance limitation during acute high-altitude exposure.
Acute Mountain Sickness
High Altitude Pulmonary Edema
High Altitude Cerebral Edema
||Observational Model: Case-Only
Time Perspective: Cross-Sectional
||Intolerance Mechanisms and Exercise Performance Limitation During a High Altitude Stay: Investigation of Sleep and Cerebral Responses
Biospecimen Retention: Samples Without DNA
| Study Start Date:
| Estimated Study Completion Date:
| Primary Completion Date:
||October 2011 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years to 50 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Respiratory, cardiac, metabolic or neuromuscular diseases
- History of severe acute mountain sickness
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||AdministrateurDRC, Principal investigator, University Hospital, Grenoble
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 26, 2012
||March 29, 2012
||France: Committee for the Protection of Personnes
Keywords provided by University Hospital, Grenoble:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 21, 2015
Central Nervous System Diseases
Nervous System Diseases
Respiratory Tract Diseases
Signs and Symptoms